What 2020 means for the life sciences
Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
- Pricing, patents and the PMPRB in Canada 14-12-2020
- The doctrine of equivalents in the medtech arena 18-11-2020
- The plausibility battleground at the EPO 09-11-2020
- A stricter interpretation: the EPO and antibodies 27-10-2020
- COVID-19: Protection of IP for AI tools 01-09-2020
Latest news
CBD company faults sparse evidence in trade secrets spat
14-01-2021
Medical cannabis company Medterra and has hit back at claims it misappropriated trade secrets at a federal court in Florida, holding that the company alleging the IP violation had failed to produce sufficient evidence.
